The New York Times: FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly

[FeedBot]

FDA Advisory Panel Endorses Approval of Alzheimer's Drug Made by Eli Lilly

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

Source: FDA Advisory Panel Endorses Approval of Alzheimer's Drug Made by Eli Lilly